OAB-040: BUMEL vs MEL-200 prior autologous transplant for patients with newly diagnosed multiple myeloma previously treated with bortezomib, lenalidomide and dexamethasone: final results of a phase 3 trial
Titel:
OAB-040: BUMEL vs MEL-200 prior autologous transplant for patients with newly diagnosed multiple myeloma previously treated with bortezomib, lenalidomide and dexamethasone: final results of a phase 3 trial
Auteur:
Palacios, Juan José Lahuerta Ubieto, Ana Jiménez Rosiñol, Laura Paiva, Bruno López, Joaquín Martinez Cedena, María Teresa Puig, Noemí Ríos, Rafael Oriol, Albert Blanchard, María Jesús Bargay, Joan Martín, Jesús martinez, Rafael Sureda, Anna De la Rubia, Javier Hernández, Miguel teodoro Cabañas, Valentín krsnik, Isabel Palomera, Luis Casado, Felipe Gonzalez-Montes, Yolanda de la Fuente, Felipe de Arriba Mateos, María-Victoria San-Miguel, Jesus Blade, Joan